Research and development daily HengRui many drugs new dynamic stone drug two products have been evaluated.

2020.07.20 Research and Development NEWS: Hengrui Pharmaceutical Injection Karelli Zhussing Single Drug Clinical Trial Approval Notice; Human Fu Pharmaceuticals RemaJulon China Approved for Listing; Johnson and Johnson AAV-RPGR Treatment X Chain Retinal Pigmentation: Can Significantly Improve Vision... We focus on the latest developments in pharmaceutical research and development, to provide research and development personnel with timely and accurate information reference.
(click on the title, read the original text) .Pharmaceutical Research and Development Johnson AAV-RPGR Treatment X Chain Retinal Pigmentation: Can significantly improve vision! Johnson and Johnson's Jansen recently announced the six-month data of the ongoing I/II trial MGT009 at the American Society of Retinal Specialists' Annual Meeting 2020.
interim data show that low- and medium-dose AAV-RPGR is well tolerated and indicates significant improvement in vision.
" Hengrui Pharmaceutical Injection With Carelli Zhusing single drug clinical trial approval notice 20, Hengrui Pharmaceuticals issued a notice that the company and subsidiaries Suzhou Shengdia Biopharmaceutical Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd. recently received the Approval of the State Drug Administration issued the "Drug Clinical Trial Approval Notice", and will be launched in the near future clinical trials.
Hengrui Pharmaceutical Salicin tablets received the drug supplement application approval notice 20, Hengrui Pharmaceuticals issued a notice that the company recently received the State Drug Administration approved the issuance of the "Drug Supplement Application Approval Notice."
Pralsetinib filed an FDA listing application on July 1, Blueprint Medicines announced on July 1 to the U.S. FDA to submit a new drug application for the treatment of patients with advanced or metastatic RET mutation thyroid myelin cancer (MTC) and RET fusion-positive thyroid cancer.
Fu Pharmaceuticals Remaazole China was approved for listing on the 20th, according to the NMPA drug approval notice, Human Fu Pharmaceuticals china's new class 1 new drug - sedatives / narcotic drugs - injection of benzosulfonate Remaazole was approved for listing.
Qilu Pharmaceutical "Aripitan capsule" first imitation approved 20, Qilu Pharmaceutical 4 generic drug Aripitan capsules approved by the State Drug Administration to market, as the same through the consistency evaluation, and for the first imitation in China.
collection variety Akabo sugar flakes! Haizheng, Shi medicine into the Bureau of 20, Haizheng and Stone Medicine declared four types of generic acapo sugar tablets were respectively approved by the State Drug Administration, as the same through the consistency evaluation.
stone pharmaceutical group "Methyl sulfonate imatini tablets" through the consistency evaluation of the 20th, stone drug group meth sulfose imartini tablets through consistency evaluation.
Imartinib is an oral tyrosine kinase inhibitor drug that is a first-line drug for the treatment of chronic myeloid leukemia (CML).
Hangzhou Minsheng Pharmaceutical "ibuprofen injection" the third approved for listing 20, Hangzhou Minsheng Pharmaceutical signed three types of generic ibuprofen injections approved by the State Drug Administration for listing, for the third domestic drug as the same as through the consistency evaluation of the enterprise.
4 new drug listing applications to be included in the priority review from Hengrui, Junshi ... On the 20th, CDE's official website announced that four new drug applications were to be included in the priority review, namely Hutchison Whampoa's Wallitini tablets, Hengrui Pharmaceuticals' sea-cupupaepa ethanolamine tablets, Keystone Pharmaceuticals' Apothini tablets and Junshi Bio's Telepuri mono-anti-injection sinned.
Sunda Biotech's new crown virus extraction kit has been certified by the European Union, Anda Biotech said today that the company's research and development of PHASIFY ™ viral RNA extraction kit has been officially certified by the European Union (CE).
.